Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.

VGXI New Manufacturing Facility Achieves Construction Milestones In Advance of 2022 Operational Date

Specialized GMP contract manufacturer VGXI, Inc. announced multiple construction milestones[…]

  Read More

VGXI, Inc. Partners with Rare Trait Hope Fund in Support of Gene Therapy for Rare Disease, AGU

Industry leading plasmid DNA Manufacturer VGXI, Inc. partners with Rare Trait Hope Fund in[…]

  Read More

VGXI Celebrates Topping Out for New Headquarters and Manufacturing Facility in Conroe, TX

Texas-based plasmid DNA Manufacturer VGXI, Inc. Celebrates the Topping Out for its New[…]

  Read More

VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies

Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical[…]

  Read More